0000899243-17-018917.txt : 20170725 0000899243-17-018917.hdr.sgml : 20170725 20170725171255 ACCESSION NUMBER: 0000899243-17-018917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170721 FILED AS OF DATE: 20170725 DATE AS OF CHANGE: 20170725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fischer Laurent CENTRAL INDEX KEY: 0001379344 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28386 FILM NUMBER: 17981064 MAIL ADDRESS: STREET 1: C/O PANACOS PHARMACEUTICALS, INC. STREET 2: 134 COOLIDGE AVENUE CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-21 0 0000891293 CTI BIOPHARMA CORP CTIC 0001379344 Fischer Laurent C/O CTI BIOPHARMA CORP. 3101 WESTERN AVE., SUITE 600 SEATTLE WA 98121 1 0 0 0 Stock Option (Right to Buy) 3.41 2017-07-21 4 A 0 50000 0.00 A 2027-07-21 Common Stock 50000 50000 D The stock options will vest on the first to occur of (1) July 21, 2018, (2) immediately prior to the first annual meeting of the Company's shareholders that occurs in 2018 and at which one or more members of the Board are to be elected, or (3) immediately prior to the occurrence of a Change in Control (as such term is defined in the 2017 Equity Incentive Plan), subject to Dr. Fischer's continued service through such date or event. /s/ Bruce J. Seeley, Attorney-in-fact for Laurent Fischer 2017-07-25